Efficacy and Safety Study of BIIB074 in Participants With Small Fiber Neuropathy

PHASE2TerminatedINTERVENTIONAL
Enrollment

265

Participants

Timeline

Start Date

May 31, 2018

Primary Completion Date

April 12, 2021

Study Completion Date

April 12, 2021

Conditions
Small Fiber NeuropathyDiabetes Mellitus
Interventions
DRUG

BIIB074

Administered as specified in the treatment arm.

DRUG

Placebo

Administered as specified in the treatment arm.

Trial Locations (97)

Unknown

Research Site, Byala

UMHAT 'Dr Georgi Stranski' EAD, Pleven

Research Site, Plovdiv

Research Site, Sofia

Vancouver General Hospital, Vancouver

Toronto General Hospital, Toronto

Research Site, Greenfield Park

Research Site, Montreal

Recherche Médicale St-Jérôme Inc., Saint-Jérôme

Research Site, Kingston

Research Site, Winnipeg

Fakultni Nemocnice Brno, Brno

Fakultni Nemocnice u sv. Anny v Brne, Brno

Research Site, Hradec Králové

Fakultni nemocnice Ostrava, Ostrava-Poruba

Nemocnice Pardubickeho kraje a.s. Pardubicka nemocnice, Pardubice

Fakultni nemocnice v Motole, Prague

Research Site, Aarhus

Research Site, Copenhagen

Research Site, Herlev

OUH, Odense

Research Site, Brest

Hopital Salengro - CHRU de Lille, Lille

CHU Saint Etienne - Hôpital Nord, Saint Priest En Jarez

CHU Clermond Ferrand - Hopital Gabriel Montpied, Clermont-Ferrand

Research Site, Vénissieux

Hôpital Ambroise Paré - Boulogne-Billancourt, Boulogne-Billancourt

Research Site, Corbeil-Essonnes

Hopital Henri Mondor, Créteil

Research Site, Le Creusot

Groupement Hospitalier Sud - Hôpital Bicêtre, Le Kremlin-Bicêtre

CHU Nice - Hôpital de l'Archet 1, Nice

Hopital Lariboisiere, Paris

Clinical Research, Böblingen

Research Site, Aschaffenburg

Research Site, Künzing

Clinical Research, Westerstede

Clinical Research, Münster

Gemeinschaftspraxis Diabeteszentrum Dortmund Dr.med. Klaus Busch, Dortmund

Hausarzt- und Diabetologische Schwerpunktpraxis, Lage

Zentrum fur Klinische Forschung, Bad Homburg

Gemeinschaftspraxis für Neurologie, Berlin

Research Site, Essen

Diabetologische Schwerpunktpraxis Harburg, Hamburg

Research Site, Mainz

DKD Helios Klinik Wiesbaden, Wiesbaden

Research Site, Würzburg

Research Site, Athens

Research Site, Heraklion

Research Site, Pátrai

AHEPA General Hospital of Thessaloniki, Thessaloniki

Research Site, Baja

Bekes Megyei Kozponti Korhaz Dr. Rethy Pal Tagkorhaz, Békéscsaba

UNO Medical Trials Kft., Budapest

Somogy Megyei Kaposi Mor Oktato Korhaz, Kaposvár

Research Site, Nyíregyháza

Research Site, Pécs

Research Site, Szeged

Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia (Presidio Spedali Civili), Brescia

Research Site, Genova

Research Site, Milan

Azienda Ospedaliero Univeraitaria Pisana, Pisa

Università Campus Bio-Medico di Roma, Roma

Research Site, Telese Terme

Amsterdam UMC, Locatie AMC, Amsterdam

Maastricht UMC+, Maastricht

Research Site, Bydgoszcz

Research Site, Chorzów

PRATIA MCM Kraków, Krakow

Research Site, Lublin

Research Site, Oświęcim

Praktyka Lekarska Ewa Krzyzagorska, Poznan

Research Site, Warsaw

Regionalna Poradnia Diabetologiczna Zytkiewicz-Jaruga,Stasinska, Wroclaw

Research Site, A Coruña

Hospital General Universitario de Alicante, Alicante

Hospital Universitari de Bellvitge, Barcelona

Research Site, Barcelona

Hospital Universitario Reina Sofia, Córdoba

Research Site, Madrid

Hospital Universitario Puerta de Hierro Majadahonda, Majadahonda

Hospital Universitari i Politecnic La Fe, Valencia

CHUV - Centre Hospitalier Universitaire Vaudois, Lausanne

Ospedale Regionale di Lugano, Lugano

Kantonspital St. Gallen, Sankt Gallen

Research Site, Zurich

Royal Hallamshire Hospital, Sheffield

Clinical Reseach, Bath

Research Site, Ipswich

Research Site, Liverpool

Guy's Hospital, London

King's College Hospital, London

St Pancras Clinical Research, London

The Royal London Hospital, London

Research Site, Manchester

John Radcliffe Hospital, Oxford

Research Site, Swansea

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Biogen

INDUSTRY